Hodgkin cells accumulate mRNA for bcl-2

Area of Science:

• Oncology
• Molecular Biology
• Immunohistochemistry

Background:

• The bcl-2 oncogene inhibits apoptosis and is implicated in lymphoma pathogenesis.
• Overexpression of bcl-2 protein and mRNA is common in follicular center cell lymphomas.
• Epstein-Barr virus-encoded late membrane protein can up-regulate bcl-2 protein.

Purpose of the Study:

• To investigate bcl-2 oncogene expression (mRNA and protein) in Hodgkin's disease.
• To correlate bcl-2 expression with late membrane protein expression.
• To analyze the 14;18 translocation in Hodgkin's disease.

Main Methods:

• Analyzed 13 Hodgkin's disease cases, 6 chronic lymphadenitis, 3 tonsils, and 13 lymphomas.
• Utilized non-isotopic in situ hybridization with a novel digoxigenin-labeled bcl-2 mRNA probe.
• Determined bcl-2 oncoprotein and late membrane protein expression via immunohistochemistry.
• Analyzed 14;18 translocation using PCR.

Main Results:

• Hodgkin cells predominantly express abundant bcl-2 mRNA across all subtypes.
• Bcl-2 oncoprotein expression was variable, highest in nodular sclerosing subtype, and not strictly correlated with late membrane protein.
• No 14;18 translocation was detected in Hodgkin's disease cases.

Conclusions:

• Hodgkin's disease exhibits high bcl-2 mRNA levels, but heterogeneous bcl-2 protein expression.
• Nodular lymphocyte predominant type shows bcl-2 mRNA/protein patterns similar to germinal center cells.
• This supports the germinal center cell origin theory for nodular lymphocyte predominant Hodgkin's disease.